ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 114 filers reported holding ARBUTUS BIOPHARMA CORP in Q4 2022. The put-call ratio across all filers is 0.57 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $55 | -6.8% | 26,735 | +4.3% | 0.00% | – |
Q2 2023 | $59 | -10.6% | 25,629 | +19.2% | 0.00% | – |
Q1 2023 | $66 | +40.4% | 21,495 | +7.2% | 0.00% | – |
Q4 2022 | $47 | -99.9% | 20,049 | +10.9% | 0.00% | – |
Q3 2022 | $35,000 | +29.6% | 18,075 | +79.3% | 0.00% | – |
Q2 2022 | $27,000 | -99.4% | 10,083 | -98.0% | 0.00% | -100.0% |
Q3 2018 | $4,700,000 | – | 497,328 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Two Seas Capital LP | 825,569 | $3,211,000 | 2.46% |
GREAT POINT PARTNERS LLC | 668,907 | $2,602,000 | 0.58% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 270,000 | $1,050,000 | 0.47% |
QCM Cayman, Ltd. | 10,205 | $40,000 | 0.24% |
Pitti Group Wealth Management, LLC | 50,000 | $195,000 | 0.22% |
RTW INVESTMENTS, LP | 2,504,493 | $9,742,000 | 0.14% |
Hudson Bay Capital Management LP | 1,805,700 | $7,024,000 | 0.07% |
Quinn Opportunity Partners LLC | 276,485 | $1,076,000 | 0.07% |
Kepos Capital LP | 200,000 | $778,000 | 0.06% |
XTX Topco Ltd | 29,026 | $113,000 | 0.06% |